FAQs on BMCA-Targeted Bispecific Antibodies in Multiple Myeloma Multiple Myeloma Research Foundation - MMRF 30:24 1 year ago 289 Скачать Далее
FAQs on Non-BCMA-Targeted Bispecific Antibodies in Multiple Myeloma Multiple Myeloma Research Foundation - MMRF 41:37 Streamed 10 months ago 361 Скачать Далее
FAQs on Bispecific Antibodies in Multiple Myeloma Multiple Myeloma Research Foundation - MMRF 52:51 Streamed 6 months ago 352 Скачать Далее
Bispecific Antibodies in Multiple Myeloma | Dana-Farber Cancer Institute Dana-Farber Cancer Institute 23:13 1 year ago 3 710 Скачать Далее
FcRH5 & GPRC5D bispecific antibodies: antigen targets beyond BCMA for multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 0:41 1 year ago 135 Скачать Далее
BCMA-targeted BiTEs for multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 8:13 2 years ago 303 Скачать Далее
The importance of BCMA-targeting ADCs and bispecific antibodies in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:28 1 year ago 126 Скачать Далее
Bispecific antibodies in multiple myeloma: teclistamab, talquetamab, and cevostamab VJHemOnc – Video Journal of Hematology & HemOnc 4:15 1 year ago 770 Скачать Далее
How BCMA targeting bispecific antibodies may impact the subsequent use of CAR-T therapy in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:15 1 year ago 71 Скачать Далее
Know Your Myeloma Immunotherapy: Bispecific Antibodies with Dr. Cesar Rodriguez HealthTree Foundation for Multiple Myeloma 57:20 2 years ago 442 Скачать Далее
Efficacy and safety of elranatamab BCMA-CD3 bispecific antibody, in patients with RRMM International Myeloma Foundation 7:06 3 years ago 1 067 Скачать Далее
Targeting BCMA with bispecific antibodies in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:23 5 years ago 116 Скачать Далее
Bispecific antibodies for myeloma: highlights from ASH 2020 VJHemOnc – Video Journal of Hematology & HemOnc 2:55 3 years ago 431 Скачать Далее
Infections following anti-BCMA bispecific antibodies for multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:53 1 year ago 217 Скачать Далее
Teclistamab, a BCMA × Cd3 Bispecific Antibody, in Pts with RRMM: Updated Phase 1 Results International Myeloma Foundation 9:57 3 years ago 1 119 Скачать Далее
Updated phase 1 results of teclistamab, a BCMA × CD3 bispecific antibody, in RRMM International Myeloma Foundation 7:25 3 years ago 393 Скачать Далее
